ストックスクリーナーアプリを入手
29.22
0.24%
-0.07
アフターアワーズ：
29.22
前日終値:
$29.29
開ける：
$29.46
24時間の取引高:
549.86K
Relative Volume:
0.65
時価総額：
$1.69B
収益：
$868.45M
当期純損益:
$158.69M
株価収益率:
10.79
EPS:
2.7087
ネットキャッシュフロー:
$328.64M
1週間 パフォーマンス:
+2.63%
1か月 パフォーマンス:
+5.83%
6か月 パフォーマンス:
+9.73%
1年 パフォーマンス:
+1.63%
1日の値動き範囲:
$29.19
$29.88
1週間の範囲:
$28.09
$29.88
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
29.22 | 1.69B | 868.45M | 158.69M | 328.64M | 2.7087 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2026-02-23 | ダウングレード | Truist | Buy → Hold |
| 2026-02-11 | 再開されました | UBS | Neutral |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Harmony Biosciences names Glenn Reicin as CFO - Investing.com
Harmony Biosciences to present at Needham Healthcare Conference - MSN
AQR Small Cap Multi-Style Fund's Harmony Biosciences Holdings Inc(HRMY) Holding History - GuruFocus
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History - Yahoo Finance
Harmony Biosciences Appoints New CFO - National Today
Harmony (HRMY) Maintains 2026 Revenue Projections of Up to $1.04 Billion - GuruFocus
Harmony Biosciences Names Glenn Reicin Finance Chief as Sandip Kapadia Departs - Moomoo
Harmony Biosciences Holdings, Inc. Reiterates Revenue Guidance for the Year 2026 - marketscreener.com
Harmony Biosciences Holdings, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Harmony Biosciences Names New CFO to Drive Growth - TipRanks
Harmony Biosciences names Glenn Reicin as CFO By Investing.com - Investing.com India
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Harmony Biosciences Names Glenn Reicin CFO, Reaffirms $1B+ Wakix Revenue Target - citybiz
New Harmony Biosciences (NASDAQ: HRMY) CFO as 2026 WAKIX revenue view held - Stock Titan
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer - Bluefield Daily Telegraph
New CFO arrives as Harmony sticks to $1B-plus 2026 sales target - Stock Titan
Harmony Biosciences Eyes $1B WAKIX Runway, Teases 2026 Pipeline Catalysts at Needham Conference - Yahoo Finance
Exit Recap: Is Harmony Biosciences Holdings Inc impacted by rising rates2026 Reactions & Low Drawdown Trading Strategies - baoquankhu1.vn
Harmony Biosciences appoints COO, updates board membership - MSN
Will Harmony’s New COO and Board Reboot Change Harmony Biosciences Holdings' (HRMY) Narrative? - simplywall.st
Analyst Upgrade: Can Harmony Biosciences Holdings Inc lead its sector in growthWeekly Earnings Recap & Weekly Market Pulse Updates - baoquankhu1.vn
Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial? - MSN
Harmony Biosciences Appoints COO, Updates Board Membership - MyChesCo
Harmony Biosciences to Present at Needham Healthcare Conference - MyChesCo
(HRMY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Can Harmony Biosciences Holdings Inc reach all time highs this yearRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Harmony Biosciences (HRMY) CCO RSUs Vest; 3,173 Shares Withheld for Taxes - Stock Titan
HRMY SEC FilingsHarmony Biosciences Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Harmony Biosciences Holdings, I (HRMY) Stock forecasts - Yahoo Finance UK
Peter Anastasiou At Harmony Biosciences Hldgs Exercises Options Worth $0 - Benzinga
Harmony Biosciences (HRMY) awards 212,241 stock options to COO Anastasiou - Stock Titan
Harmony Biosciences (HRMY) director granted 17,710 stock options at $27.74 strike - Stock Titan
Harmony Biosciences (HRMY) director Troy Ignelzi files initial Form 3 - Stock Titan
Harmony Biosciences Holdings, Inc. (HRMY) stock price, news, quote and history - uk.finance.yahoo.com
Harmony Biosciences Holdings, Inc. ($HRMY) CEO 2025 Pay Revealed - Quiver Quantitative
Harmony Biosciences Holdings (HRMY) Valuation After New COO And Board Appointments - Yahoo Finance
Harmony Biosciences Appoints Peter Anastasiou as Chief Operating Officer - The Globe and Mail
[ARS] Harmony Biosciences Holdings, Inc. SEC Filing - Stock Titan
Executive pay and board elections at Harmony Biosciences (HRMY) 2026 virtual meeting - Stock Titan
A Look At Harmony Biosciences Holdings (HRMY) Valuation After Recent Share Price Weakness - Sahm
Harmony Biosciences names Peter Anastasiou as chief operating officer By Investing.com - Investing.com India
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):